Term ends Oct 24, 2030 · High confidence
20-year base term ends Dec 11, 2026
Held by Hoffmann-La Roche Inc.
Filed May 27, 2009 as application 12/086,309 · Granted Dec 9, 2014
Base term plus 1413 days of patent term adjustment (USPTO delay)
Today
2006
2030
Clock starts
Dec 11, 2006
Dec 11, 2006
Term ends
Oct 24, 2030
Oct 24, 2030
Granted
Dec 9, 2014
Dec 9, 2014
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,413
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1413 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 11, 2006, when application PCT/EP2006/011914, the earliest non-provisional in its chain, was filed (this one was filed May 27, 2009) | Dec 11, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1413 days, USPTO patent term adjustment record | Oct 24, 2030 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 24, 2030 | High confidence |
This family
| US 8,906,370 | this patent Oct 2030 | Oct 2030 |
| US 9,272,031 | In force Dec 2026 | Dec 2026 |
2 of 3 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 2, 2009 Reel 22766, frame 529 | Loetscher, Hansruedi; Huber, Walter; Schuhbauer, Diana; Weyer, Karl; Brockhaus, Manfred; Bohrmann, Bernd; Koll, Hans; Schaubmar, Andreas; Lang, Kurt | F. Hoffmann-La Roche AG | Assignment of Assignor's Interest |
| Sep 20, 2012 Reel 28994, frame 145 | F. Hoffmann-La Roche AG | Hoffmann-La Roche Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2030
Term ends Oct 24, 2030.
Note
The 1413 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
16
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.